Company Profile

Aspira Biosystems Inc
Profile last edited on: 5/29/21      CAGE:       UEI:

Business Identifier: Biotechnical Research
Year Founded
First Award
Latest Award
Program Status
Inactive (Acquired)
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

849 Mitten Road Suite 101
Burlingame, CA 94010
   (650) 873-0412
Location: Single
Congr. District: 14
County: San Mateo

Public Profile

In July 2004, Aspira Biosystems Inc was acquired by Nanomune Technologies, Inc and has not been SBIR since then. Aspira Biosystems is developing advanced capture agents and protein biochips for predictable proteomics. Our products are based on a unique patent-pending platform technology, called ProteinPrintTM, which enables sequence-based separation and high-throughput analysis of known and unknown proteins. Aspira's ProteinPrint technology represents a major breakthrough for the biopharmaceutical industry. Protein research and drug discovery laboratories that have identified proteins of interest using gel electrophoresis, high-throughput gene analyses or database searches can rapidly obtain highly specific capture agents for target validation and high-throughput screening

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2003 2 NIH $1,217,750
Project Title: An Artificial Sequence-Based Protein Receptor Array

Key People / Management

  Casey Lynch -- President

  Chin-Shiou Huang

Company News

There are no news available.